HK Stock MarketDetailed Quotes

02561 VISEN PHARMA-B

Watchlist
  • 45.150
  • +1.200+2.73%
Market Closed May 2 16:08 CST
5.14BMarket Cap-26.14P/E (TTM)

VISEN PHARMA-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Operating income
Operating expenses
Gross profit
Administrative expenses
-8.12%-86.43M
-0.50%-64.39M
54.95%-79.94M
---64.06M
-1.78%-177.45M
-1,002.01%-174.35M
---15.82M
Research and development expenses
-56.91%-90.52M
-54.68%-58.91M
67.87%-57.69M
---38.08M
34.54%-179.55M
-320.69%-274.28M
---65.2M
Special items of operating profit
95.41%-5.13M
94.27%-6.07M
-262.60%-111.62M
---105.95M
438.60%68.65M
-43.40%-20.27M
---14.14M
Operating profit
26.95%-182.08M
37.83%-129.37M
13.56%-249.25M
-208.09M
38.51%-288.35M
-392.77%-468.9M
-95.16M
Financing cost
49.21%-161K
47.98%-129K
48.79%-317K
---248K
15.67%-619K
-140.66%-734K
---305K
Adjustment items of  earning before tax
----
----
----
----
----
-331.40%-15.14M
---3.51M
Earning before tax
26.98%-182.24M
37.84%-129.5M
13.63%-249.57M
-208.34M
40.39%-288.97M
-389.82%-484.78M
-98.97M
After-tax profit from continuing operations
26.98%-182.24M
37.84%-129.5M
13.63%-249.57M
-208.34M
40.39%-288.97M
-389.82%-484.78M
-98.97M
Earning after tax
26.98%-182.24M
37.84%-129.5M
13.63%-249.57M
-208.34M
40.39%-288.97M
-389.82%-484.78M
-98.97M
Profit attributable to shareholders
26.98%-182.24M
37.84%-129.5M
13.63%-249.57M
-208.34M
40.39%-288.97M
-389.82%-484.78M
-98.97M
Basic earnings per share
26.97%-1.95
-2.67
Diluted earnings per share
26.97%-1.95
-2.67
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
(FY)Dec 31, 2024(Q9)Sep 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Operating income
Operating expenses
Gross profit
Administrative expenses -8.12%-86.43M-0.50%-64.39M54.95%-79.94M---64.06M-1.78%-177.45M-1,002.01%-174.35M---15.82M
Research and development expenses -56.91%-90.52M-54.68%-58.91M67.87%-57.69M---38.08M34.54%-179.55M-320.69%-274.28M---65.2M
Special items of operating profit 95.41%-5.13M94.27%-6.07M-262.60%-111.62M---105.95M438.60%68.65M-43.40%-20.27M---14.14M
Operating profit 26.95%-182.08M37.83%-129.37M13.56%-249.25M-208.09M38.51%-288.35M-392.77%-468.9M-95.16M
Financing cost 49.21%-161K47.98%-129K48.79%-317K---248K15.67%-619K-140.66%-734K---305K
Adjustment items of  earning before tax ---------------------331.40%-15.14M---3.51M
Earning before tax 26.98%-182.24M37.84%-129.5M13.63%-249.57M-208.34M40.39%-288.97M-389.82%-484.78M-98.97M
After-tax profit from continuing operations 26.98%-182.24M37.84%-129.5M13.63%-249.57M-208.34M40.39%-288.97M-389.82%-484.78M-98.97M
Earning after tax 26.98%-182.24M37.84%-129.5M13.63%-249.57M-208.34M40.39%-288.97M-389.82%-484.78M-98.97M
Profit attributable to shareholders 26.98%-182.24M37.84%-129.5M13.63%-249.57M-208.34M40.39%-288.97M-389.82%-484.78M-98.97M
Basic earnings per share 26.97%-1.95-2.67
Diluted earnings per share 26.97%-1.95-2.67
Currency Unit CNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor ----Ernst & Young--Ernst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

BRK cash at new high: What to expect from Buffett’s meeting?
🎙️Discussion 1. Buffett said he won't sell Japanese stocks for the next ten years. What's your take? 2. In the face of market changes, do y Show More